Oncomicrobial vaccines mitigate tumor progression via precisely targeting oncomicrobes in mice

References

[1] Boleij A, Hechenbleikner EM, Goodwin AC et al. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin Infect Dis 2015;60:208–215.

[2] Cougnoux A, Delmas J, Gibold L et al. Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria. Gut 2016;65:278–285.

[3] Cullin N, Azevedo Antunes C, Straussman R et al. Microbiome and cancer. Cancer Cell 2021;39:1317–1341.

[4] Garland SM, Kjaer SK, Muñoz N et al. Impact and effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience. Clin Infect Dis 2016;63:519–527.

[5] He Z, Gharaibeh RZ, Newsome RC et al. Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin. Gut 2019;68:289–300.

[6] Holt RA. Oncomicrobial vaccines: the potential for a Fusobacterium nucleatum vaccine to improve colorectal cancer outcomes. Cell Host Microbe 2023;31:141–145.

[7] Ren J, Sui H, Fang F et al. The application of Apc^(Min/+) mouse model in colorectal tumor researches. J Cancer Res Clin Oncol 2019;145:1111–1122.

[8] Rubinstein MR, Wang X, Liu W et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 2013;14:195–206.

[9] Sears CL, Geis AL, Housseau F. Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis. J Clin Invest 2014;124:4166–4172.

[10] Spaander MCW, Zauber AG, Syngal S et al. Young-onset colorectal cancer. Nat Rev Dis Primers 2023;9:21.

[11] Takeuchi T, Kameyama K, Miyauchi E et al. Fatty acid overproduction by gut commensal microbiota exacerbates obesity. Cell Metab 2023;35:361–375.e9.

[12] Wagner VE, Dey N, Guruge J et al. Effects of a gut pathobiont in a gnotobiotic mouse model of childhood undernutrition. Sci Transl Med 2016;8:366ra164.

[13] Wexler HM. Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev 2007;20:593–621.

[14] Wu S, Rhee KJ, Albesiano E et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 2009;15:1016–1022.

[15] Yang Q, Wang B, Zheng Q et al. A review of gut microbiota-derived metabolites in tumor progression and cancer therapy. Adv Sci (Weinh) 2023;10: e2207366.

RIGHTS & PERMISSIONS

The Author(s) 2025. Published by Oxford University Press on behalf of Higher Education Press.